AlphaCentric Advisors »

Annexon shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Annexon (ANNX) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Annexon

Tip: Access up to 7 years of quarterly data

All positions including Annexon held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Annexon by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $136k 25k 5.54

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Astrazeneca Ord (AZN)
Vertex Pharmaceuticals Incorporated (VRTX)
Euronet Worldwide (EEFT)
Invitation Homes (INVH)
Ionis Pharmaceuticals (IONS)
Insmed Com Par $.01 (INSM)
Incyte Corporation (INCY)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
AMREP Corporation (AXR)
Saul Centers (BFS)

View all positions for AlphaCentric Advisors

Top funds holding Annexon

Redmile Group
BlackRock
FMR
BVF
Vanguard Group
Vanguard Capital Management
Adage Capital Partners GP
Bain Capital Life Sciences Investors
Bellevue Group
MAK Capital One
State Street Corporation
Bank of America Corporation
Nuveen
Balyasny Asset Management
Ameriprise Financial

View all funds holding Annexon